205 related articles for article (PubMed ID: 23358429)
41. Human osteosarcoma expresses specific ephrin profiles: implications for tumorigenicity and prognosis.
Varelias A; Koblar SA; Cowled PA; Carter CD; Clayer M
Cancer; 2002 Aug; 95(4):862-9. PubMed ID: 12209731
[TBL] [Abstract][Full Text] [Related]
42. Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression.
Brantley-Sieders DM; Fang WB; Hicks DJ; Zhuang G; Shyr Y; Chen J
FASEB J; 2005 Nov; 19(13):1884-6. PubMed ID: 16166198
[TBL] [Abstract][Full Text] [Related]
43. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
[TBL] [Abstract][Full Text] [Related]
44. Potential clinical relevance of Eph receptors and ephrin ligands expressed in prostate carcinoma cell lines.
Fox BP; Tabone CJ; Kandpal RP
Biochem Biophys Res Commun; 2006 Apr; 342(4):1263-72. PubMed ID: 16516143
[TBL] [Abstract][Full Text] [Related]
45. Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.
Nakamoto M; Bergemann AD
Microsc Res Tech; 2002 Oct; 59(1):58-67. PubMed ID: 12242697
[TBL] [Abstract][Full Text] [Related]
46. Coexpression of EphB4 and ephrinB2 in tumor advancement of uterine cervical cancers.
Alam SM; Fujimoto J; Jahan I; Sato E; Tamaya T
Gynecol Oncol; 2009 Jul; 114(1):84-8. PubMed ID: 19356789
[TBL] [Abstract][Full Text] [Related]
47. Ephrin-A1 is a negative regulator in glioma through down-regulation of EphA2 and FAK.
Liu DP; Wang Y; Koeffler HP; Xie D
Int J Oncol; 2007 Apr; 30(4):865-71. PubMed ID: 17332925
[TBL] [Abstract][Full Text] [Related]
48. Up-regulation of EphB and ephrin-B expression in rhabdomyosarcoma.
Berardi AC; Marsilio S; Rofani C; Salvucci O; Altavista P; Perla FM; Diomedi-Camassei F; Uccini S; Kokai G; Landuzzi L; McDowell HP; Dominici C
Anticancer Res; 2008; 28(2A):763-9. PubMed ID: 18507018
[TBL] [Abstract][Full Text] [Related]
49. Ephrin-A1 inhibits NSCLC tumor growth via induction of Cdx-2 a tumor suppressor gene.
Sukka-Ganesh B; Mohammed KA; Kaye F; Goldberg EP; Nasreen N
BMC Cancer; 2012 Jul; 12():309. PubMed ID: 22824143
[TBL] [Abstract][Full Text] [Related]
50. Human endometrial epithelial cells express ephrin A1: possible interaction between human blastocysts and endometrium via Eph-ephrin system.
Fujiwara H; Yoshioka S; Tatsumi K; Kosaka K; Satoh Y; Nishioka Y; Egawa M; Higuchi T; Fujii S
J Clin Endocrinol Metab; 2002 Dec; 87(12):5801-7. PubMed ID: 12466389
[TBL] [Abstract][Full Text] [Related]
51. The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand.
Yang NY; Lopez-Bergami P; Goydos JS; Yip D; Walker AM; Pasquale EB; Ethell IM
Pigment Cell Melanoma Res; 2010 Oct; 23(5):684-7. PubMed ID: 20649938
[No Abstract] [Full Text] [Related]
52. Ephrin stimulation modulates T cell chemotaxis.
Sharfe N; Freywald A; Toro A; Dadi H; Roifman C
Eur J Immunol; 2002 Dec; 32(12):3745-55. PubMed ID: 12516569
[TBL] [Abstract][Full Text] [Related]
53. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202
[TBL] [Abstract][Full Text] [Related]
54. Perturbation of the EphA2-EphrinA1 system in human prostate cancer cells by colonic (poly)phenol catabolites.
Tognolini M; Giorgio C; Hassan Mohamed I; Barocelli E; Calani L; Reynaud E; Dangles O; Borges G; Crozier A; Brighenti F; Del Rio D
J Agric Food Chem; 2012 Sep; 60(36):8877-84. PubMed ID: 22409255
[TBL] [Abstract][Full Text] [Related]
55. Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells.
Zhou N; Zhao WD; Liu DX; Liang Y; Fang WG; Li B; Chen YH
Microvasc Res; 2011 Sep; 82(2):113-21. PubMed ID: 21726568
[TBL] [Abstract][Full Text] [Related]
56. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
[TBL] [Abstract][Full Text] [Related]
57. Higher expression of EphA2 and ephrin-A1 is related to favorable clinicopathological features in pathological stage I non-small cell lung carcinoma.
Ishikawa M; Miyahara R; Sonobe M; Horiuchi M; Mennju T; Nakayama E; Kobayashi M; Kikuchi R; Kitamura J; Imamura N; Huang CL; Date H
Lung Cancer; 2012 Jun; 76(3):431-8. PubMed ID: 22236865
[TBL] [Abstract][Full Text] [Related]
58. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
59. EphA2/Ephrin-A1 signaling complexes restrict corneal epithelial cell migration.
Kaplan N; Fatima A; Peng H; Bryar PJ; Lavker RM; Getsios S
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):936-45. PubMed ID: 22247486
[TBL] [Abstract][Full Text] [Related]
60. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
